Want to join the conversation?
$PAHC reported improved earnings in 4Q16, helped by foreign currency gains compared to 4Q15. Net income was $15.2MM or $0.38 per diluted share compared to $10.4MM or $0.26 per diluted share last year. Net sales grew 2% from 4Q15 to $189MM. Adjusted diluted EPS fell 9% to $0.40 in 4Q16.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.